Kala Bio Hires Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

Wednesday, Apr 1, 2026 6:46 am ET1min read
KALA--

Kala Bio has engaged Dr. Saeid Babaei as a Senior Scientific Advisor to evaluate clinical assets and precision development opportunities. The focus will be on applying AI-enabled analytics and digital health tools to Kala's MSC Secretome platform. The aim is to unlock value through amended indications, assess hypotheses related to potential responder subgroups, and develop a regulatory-conscious analytical framework. The collaboration marks a pivotal step in Kala Bio's strategy to maximize commercial and scientific value.

Kala Bio Hires Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet